PathMaker Announces First-In-Human Trial of Neurostimulation Device MyoRegulator in ALS
Neurology Live,
In the study, patients with ALS will be asked to complete questionnaires, a physical examination, and undergo neurostimulation…
In the study, patients with ALS will be asked to complete questionnaires, a physical examination, and undergo neurostimulation…
/PRNewswire/ -- PathMaker Neurosystems Inc. ("PathMaker"), a clinical-stage bioelectronic medicine company developing…
/PRNewswire/ -- PathMaker Neurosystems Inc. ("PathMaker"), a clinical-stage bioelectronic medicine company developing…
PathMaker Neurosystems Inc. ("PathMaker"), a clinical-stage bioelectronic medicine company developing breakthrough non-invasive…